Clinical Trials List
Protocol NumberYSP-RIH3001-01
Not yet recruiting
2016-05-01 - 2017-04-30
Others
Terminated1
xxxxxx
-
Sponsor
xxxxxx
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
xxxxxx
Objectives
xxxxxx
Test Drug
xxxxxx
Active Ingredient
xxxxxx
Dosage Form
110
Dosage
200毫克
Endpoints
xxxxxx
Inclution Criteria
xxxxxx
Exclusion Criteria
xxxxxx
The Estimated Number of Participants
-
Taiwan
28 participants
-
Global
28 participants
